Scinovex
articleTop 1% cited

Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms

The American Journal of Surgical Pathology · 2002 · Vol. 26(3) · pp. 281–291
Mahul B. AminMitual AminPheroze TamboliJavid JavidanHans StrickerMariza De-Peralta VenturinaAnita DeshpandeMani Menon

Abstract

Just two and a half decades ago adult renal cell neoplasms, i.e., those arising from the renal tubules or collecting duct epithelium, were subdivided into two major subtypes: "clear cell carcinoma" and "granular cell carcinoma." Subsequent detailed morphologic and/or cytogenetic studies have resulted in the recognition of several distinctive subtypes of adult renal epithelial neoplasms, which has led to the promulgation of a refined contemporary histologic classification of these tumors. This study examines the prognostic significance of histologic subtyping in accordance with the new classification in a consecutive series of 405 cases treated at a single institution. Cases were histologically classified into 28 (7%) benign tumors [27 (6.7%) renal oncocytomas, 1 (0.2%) metanephric adenoma] and 377 (93%) malignant tumors [255 (63%) conventional (clear cell) renal cell carcinoma, 75 (18.5%) papillary renal cell carcinoma, 24 (5.9%) chromophobe renal cell carcinoma, and 23 (5.7%) renal cell carcinoma, unclassified]. A total of 25 (6.6%) malignant tumors showed evidence of sarcomatoid change. Kaplan-Meier survival analysis with log-rank test showed histologic type (p = 0.002), Fuhrman's nuclear grade (p = 0.001), TNM stage (p = 0.001), vascular invasion (p = 0.001), and necrosis (p = 0.001) to be significantly associated with disease-specific survival and progression-free survival, based on follow-up of 368 patients (mean 64.5 months, median 56 months). The 5-year disease-specific survival for chromophobe renal cell carcinoma, papillary renal cell carcinoma, conventional (clear cell) renal cell carcinoma, and renal cell carcinoma, unclassified was 100%, 86%, 76%, and 24%, respectively; no patient with a benign tumor diagnosis progressed or died of disease. The 5-year progression-free survival for chromophobe renal cell carcinoma, papillary renal cell carcinoma, conventional (clear cell) renal cell carcinoma, and renal cell carcinoma, unclassified was 94%, 88%, 70%, and 18%, respectively. Malignant tumors with sarcomatoid change had a 35% and 27%, 5-year disease-specific and progression-free survival, respectively. Cox proportional hazards regression analysis showed TNM stage (p = 0.001), nuclear grade (p = 0.01), and necrosis (p = 0.05) to be significant predictors of disease-specific survival. In conclusion, our study shows that the histologic categorization of adult renal epithelial neoplasms performed by routine light microscopic hematoxylin and eosin-based examination in accordance with the contemporary classification scheme has prognostic utility.

Renal cell carcinoma treatmentCancer Genomics and DiagnosticsRenal and related cancersChromophobe cellPathologyClear cellOncocytomaMedicineRenal cell carcinomaCarcinomaClear cell carcinomaPapillary renal cell carcinomasNephrectomy

MeSH terms

AdolescentAdultAgedAged, 80 and overCarcinoma, Renal CellFemaleHumansKidney NeoplasmsMaleMiddle AgedPrognosisAdenoma, Oxyphilic
Citations
727
FWCI
24.97
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
References
Prognostic significance of morphologic parameters in renal cell carcinoma
The American Journal of Surgical Pathology · 1982 · 2,738 citations
The Heidelberg classification of renal cell tumours
The Journal of Pathology · 1997 · 1,320 citations
Sarcomatoid Differentiation in Renal Cell Carcinoma
The American Journal of Surgical Pathology · 2001 · 504 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.